These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 22496318)
1. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Bumbacea D; Arend SM; Eyuboglu F; Fishman JA; Goletti D; Ison MG; Jones CE; Kampmann B; Kotton CN; Lange C; Ljungman P; Milburn H; Morris MI; Muller E; Muñoz P; Nellore A; Rieder HL; Sester U; Theodoropoulos N; Wagner D; Sester M Eur Respir J; 2012 Oct; 40(4):990-1013. PubMed ID: 22496318 [TBL] [Abstract][Full Text] [Related]
2. Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of Taiwan. Chiang CY; Chen CH; Feng JY; Chiang YJ; Huang WC; Lin YJ; Huang YW; Wu HH; Lee PH; Lee MC; Shu CC; Wang HH; Wang JY; Wu MY; Lee CY; Wu MS J Formos Med Assoc; 2023 Oct; 122(10):976-985. PubMed ID: 37183074 [TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis in solid organ transplant donors and recipients. Malinis M; Koff A Curr Opin Organ Transplant; 2021 Aug; 26(4):432-439. PubMed ID: 34074939 [TBL] [Abstract][Full Text] [Related]
4. Incidence, Outcomes, and Long-term Immune Response to Tuberculosis in Organ Transplant Recipients. Natori Y; Ferreira VH; Nellimarla S; Husain S; Rotstein C; Humar A; Kumar D Transplantation; 2019 Jan; 103(1):210-215. PubMed ID: 29944616 [TBL] [Abstract][Full Text] [Related]
6. Prevention and Management of Tuberculosis in Transplant Recipients: From Guidelines to Clinical Practice. Muñoz L; Santin M Transplantation; 2016 Sep; 100(9):1840-52. PubMed ID: 27306535 [TBL] [Abstract][Full Text] [Related]
7. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Sester M; van Leth F; Bruchfeld J; Bumbacea D; Cirillo DM; Dilektasli AG; Domínguez J; Duarte R; Ernst M; Eyuboglu FO; Gerogianni I; Girardi E; Goletti D; Janssens JP; Julander I; Lange B; Latorre I; Losi M; Markova R; Matteelli A; Milburn H; Ravn P; Scholman T; Soccal PM; Straub M; Wagner D; Wolf T; Yalcin A; Lange C; Am J Respir Crit Care Med; 2014 Nov; 190(10):1168-76. PubMed ID: 25303140 [TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of tuberculosis in solid organ transplant recipients. Abad CL; Razonable RR Expert Rev Anti Infect Ther; 2020 Jan; 18(1):63-73. PubMed ID: 31826668 [No Abstract] [Full Text] [Related]
9. Positivity rate of interferon-γ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan. Igari H; Akutsu N; Ishikawa S; Aoyama H; Otsuki K; Hasegawa M; Maruyama M; Tsuyuzaki M; Suzuki K; Saigo K J Infect Chemother; 2019 Jul; 25(7):537-542. PubMed ID: 30905632 [TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis: Active disease and latent infection in a renal transplant cohort. Rafiei N; Williams J; Mulley WR; Trauer JM; Jenkin GA; Rogers BA Nephrology (Carlton); 2019 May; 24(5):569-574. PubMed ID: 29660203 [TBL] [Abstract][Full Text] [Related]
11. Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey. Cantini F; Lubrano E; Marchesoni A; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Spadaro A Int J Rheum Dis; 2016 Aug; 19(8):799-805. PubMed ID: 26172207 [TBL] [Abstract][Full Text] [Related]